Our Mission

  Impact medicine through the development of machine learning based AI infrastructure and tools that can bring to light extraordinary “hidden” clinical insights that lie within existing medical data

Extraordinary Clinical Insights from Ordinary Medical Data

Medial EarlySign develops a platform for producing machine learning based clinical decision-support solutions that extract a wide range of clinical insights from existing medical data and lab results.  The company is developing a suite of clinical tools impacting the early detection of cancers and other diverse medical conditions, and implementing them at various healthcare organizations worldwide.   Our goal is that these insights will be accessible by all stakeholders including healthcare organizations, doctors and eventually patients.   We believe that by doing this we can help change the way medicine is practiced today

Learn More >
On the Intersection of Big Data & Healthcare

Integrating cutting edge machine learning science with clinical expertise

Learn More >
Clinical Research

Ongoing clinical trials in 14 leading institutions around the world

Learn More >


A machine learning based, data-driven decision support software tool, ColonFlag identifies a subset of the population with a high probability for harboring colorectal cancer (CRC) or precancerous lesions by analyzing only conventional blood test results, age and sex. ColonFlag can make these identifications often months before clinical signs are present and enabling healthcare organizations to reach out to individuals who are not up to date with their CRC screening.
Learn More >